BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 28952018)

  • 21. Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A
    Radiol Med; 2018 Jul; 123(7):535-537. PubMed ID: 29560604
    [No Abstract]   [Full Text] [Related]  

  • 22. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
    Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
    Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
    Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
    Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.
    Radbruch A; Weberling LD; Kieslich PJ; Eidel O; Burth S; Kickingereder P; Heiland S; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2015 Jun; 275(3):783-91. PubMed ID: 25848905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
    Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
    Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
    Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
    Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Invest Radiol; 2015 Dec; 50(12):805-10. PubMed ID: 26523910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
    Splendiani A; Corridore A; Torlone S; Martino M; Barile A; Di Cesare E; Masciocchi C
    Insights Imaging; 2019 Sep; 10(1):82. PubMed ID: 31482392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
    Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
    Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
    Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
    Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
    Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
    Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
    Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
    Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
    Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
    Schlemm L; Chien C; Bellmann-Strobl J; Dörr J; Wuerfel J; Brandt AU; Paul F; Scheel M
    Mult Scler; 2017 Jun; 23(7):963-972. PubMed ID: 27679460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol.
    Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR
    Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.